Global MicroRNA Consumables Market

MicroRNA Consumables Comprehensive Study by Type (Instruments, Consumables), Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), End Use (Biotechnology, Pharmaceutical Companies, Academic, Government Research Institutes, Others), Service (Isolation & Purification, Quantification & Detection, Functional Analysis, Others) Players and Region - Global Market Outlook to 2028

MicroRNA Consumables Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global MicroRNA Consumables Market Overview:
A microRNA consumable (abbreviated miRNA) is a small single-stranded non-coding RNA molecule found in plants, animals, and some viruses that functions in RNA silencing and post-transcriptional gene expression regulation. MiRNAs work by pairing with complementary sequences in mRNA molecules. As a result, these mRNA molecules are silenced by one or more of the following processes: mRNA strand cleavage into two pieces; mRNA destabilization via shortening of its poly tail; and less efficient translation of the mRNA into proteins by ribosomes. MiRNAs are similar to small interfering RNAs (siRNAs) from the RNA interference (RNAi) pathway, except that miRNAs are derived from RNA transcripts that fold back on themselves to form short hairpins, whereas siRNAs are derived from longer double-stranded RNA regions. The human genome may contain over 1900 miRNAs, though newer research suggests that the figure is closer to 2,300. However, in the manually curated miRNA gene database MirGeneDB, only about 500 human microRNAs are genuine microRNAs.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Advance Methodologies Used for MicroRNA Consumables, RNA Sequencing, and Microarray and Rapid Advancement of Technology in Both Consumer and Industrial Markets

Market Growth Drivers:
High Prevalence and Rise of Cancer Neurological Disorder and Other Medical Conditions and Increased R&D Investments by Government Institute and Biotechnology Companies

Challenges:
Rapid Market Technological Changes in Conjunction with High Consumer Demand and Exact Administration of These Molecules to a Specific Intracellular Location Can Hinder the Growth of MicroRNA Consumables Market

Restraints:
High Cost Associated with the MicroRNA Consumables Can Constrain the MicroRNA Consumables Market and Risk of Eliciting False-Negative and False-Positive Results

Opportunities:
Development of Genomic Technology and Computational Approaches Can Grow the MicroRNA Consumables Market and Advantages Such as Including Ease of Implementation and Compatibility for a Wide Range of MicroRNA Consumables

Competitive Landscape:
The market for microRNA consumables is fiercely competitive, with several large biopharmaceutical companies having a strong presence. The expansion of a patent portfolio is a key growth strategy pursued by keen players in the microRNA market. Sistemic Ltd., for example, announced the expansion of its patent covering the use of microRNAs for predictive analysis of cellular function in July 2020. The patent covers the microRNA expression study of mesenchymal stem cells obtained from various donors to identify miRNAs that will later be linked to cellular functions to support donor screening and develop MSC-based cell therapies.
Some of the key players profiled in the report are Thermo Fisher Scientific (United States), Agilent Technologies (United States), Merck KGaA (Germany), Exiqon A/S (Denmark), NanoString Technologies (United States), GE Healthcare Dharmacon, Inc. (United States), Synlogic (United States), GeneCopoeia, Inc. (United States), New England Biolabs (United States) and Quantabio (United States). Additionally, following companies can also be profiled that are part of our coverage like BioGenex (United States), SeqMatic LLC (United States), Miltenyi Biotec (Germany) and Others. Analyst at AMA Research see United States Players to retain maximum share of Global MicroRNA Consumables market by 2028. Considering Market by End Use, the sub-segment i.e. Biotechnology will boost the MicroRNA Consumables market. Considering Market by Service, the sub-segment i.e. Isolation & Purification will boost the MicroRNA Consumables market.

Latest Market Insights:
On 5th January 2022, Thermo Fisher Scientific Inc., the world leader in science services, and PeproTech, Inc., a leading developer, and manufacturer of recombinant proteins, announced that Thermo Fisher has completed its acquisition of PeproTech for approximately USD1.85 billion in cash.

On 27th July 2022, Miltenyi Biotec, a global provider of biomedical research and cellular therapy products and services, announced the Class III certification of all its CliniMACS Reagents for clinical-scale cell separation under the new European Regulation EU 2017/745 on medical devices. These reagents are used in a wide range of cell processing applications and are crucial in cell and gene therapies such as stem cell transplantation.

Kim is engaged in the regulation of microRNA function. Untemplated nucleotides, usually A or U, are added to the 3' end or tail of a small percentage of microRNAs. Tailing can change the function of microRNAs and, in some cases, act as a molecular switch, resulting in developmental and pathological changes. Kim's lab was curious about whether tailing occurs on other RNAs, such as mRNA. They devised a novel method for sequencing mRNA's 3' tail region, allowing them to measure polyA tail length and detect 3' terminal modifications. They discovered widespread uridylation of mRNAs and demonstrated that the 3' PolyU modification serves to mark mRNAs for decay.

What Can be Explored with the MicroRNA Consumables Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global MicroRNA Consumables Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in MicroRNA Consumables
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global MicroRNA Consumables market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in MicroRNA Consumables market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, MicroRNA Consumables Manufacturers, MicroRNA Consumables Suppliers & Distributors, High-Quality technology Products, Brand Value and recognition, Government Bodies, End-Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Consumables
By Application
  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others
By End Use
  • Biotechnology
  • Pharmaceutical Companies
  • Academic
  • Government Research Institutes
  • Others

By Service
  • Isolation & Purification
  • Quantification & Detection
  • Functional Analysis
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence and Rise of Cancer Neurological Disorder and Other Medical Conditions
      • 3.2.2. Increased R&D Investments by Government Institute and Biotechnology Companies
    • 3.3. Market Challenges
      • 3.3.1. Rapid Market Technological Changes in Conjunction with High Consumer Demand
      • 3.3.2. Exact Administration of These Molecules to a Specific Intracellular Location Can Hinder the Growth of MicroRNA Consumables Market
    • 3.4. Market Trends
      • 3.4.1. Advance Methodologies Used for MicroRNA Consumables, RNA Sequencing, and Microarray
      • 3.4.2. Rapid Advancement of Technology in Both Consumer and Industrial Markets
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global MicroRNA Consumables, by Type, Application, End Use, Service and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global MicroRNA Consumables (Value)
      • 5.2.1. Global MicroRNA Consumables by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Consumables
      • 5.2.2. Global MicroRNA Consumables by: Application (Value)
        • 5.2.2.1. Cancer
        • 5.2.2.2. Infectious Diseases
        • 5.2.2.3. Immunological Disorder
        • 5.2.2.4. Cardiovascular Disease
        • 5.2.2.5. Neurological Disease
        • 5.2.2.6. Others
      • 5.2.3. Global MicroRNA Consumables by: End Use (Value)
        • 5.2.3.1. Biotechnology
        • 5.2.3.2. Pharmaceutical Companies
        • 5.2.3.3. Academic
        • 5.2.3.4. Government Research Institutes
        • 5.2.3.5. Others
      • 5.2.4. Global MicroRNA Consumables by: Service (Value)
        • 5.2.4.1. Isolation & Purification
        • 5.2.4.2. Quantification & Detection
        • 5.2.4.3. Functional Analysis
        • 5.2.4.4. Others
      • 5.2.5. Global MicroRNA Consumables Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global MicroRNA Consumables (Price)
      • 5.3.1. Global MicroRNA Consumables by: Type (Price)
  • 6. MicroRNA Consumables: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Exiqon A/S (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NanoString Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare Dharmacon, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Synlogic (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GeneCopoeia, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. New England Biolabs (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Quantabio (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global MicroRNA Consumables Sale, by Type, Application, End Use, Service and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global MicroRNA Consumables (Value)
      • 7.2.1. Global MicroRNA Consumables by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Consumables
      • 7.2.2. Global MicroRNA Consumables by: Application (Value)
        • 7.2.2.1. Cancer
        • 7.2.2.2. Infectious Diseases
        • 7.2.2.3. Immunological Disorder
        • 7.2.2.4. Cardiovascular Disease
        • 7.2.2.5. Neurological Disease
        • 7.2.2.6. Others
      • 7.2.3. Global MicroRNA Consumables by: End Use (Value)
        • 7.2.3.1. Biotechnology
        • 7.2.3.2. Pharmaceutical Companies
        • 7.2.3.3. Academic
        • 7.2.3.4. Government Research Institutes
        • 7.2.3.5. Others
      • 7.2.4. Global MicroRNA Consumables by: Service (Value)
        • 7.2.4.1. Isolation & Purification
        • 7.2.4.2. Quantification & Detection
        • 7.2.4.3. Functional Analysis
        • 7.2.4.4. Others
      • 7.2.5. Global MicroRNA Consumables Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global MicroRNA Consumables (Price)
      • 7.3.1. Global MicroRNA Consumables by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. MicroRNA Consumables: by Type(USD Million)
  • Table 2. MicroRNA Consumables Instruments , by Region USD Million (2017-2022)
  • Table 3. MicroRNA Consumables Consumables , by Region USD Million (2017-2022)
  • Table 4. MicroRNA Consumables: by Application(USD Million)
  • Table 5. MicroRNA Consumables Cancer , by Region USD Million (2017-2022)
  • Table 6. MicroRNA Consumables Infectious Diseases , by Region USD Million (2017-2022)
  • Table 7. MicroRNA Consumables Immunological Disorder , by Region USD Million (2017-2022)
  • Table 8. MicroRNA Consumables Cardiovascular Disease , by Region USD Million (2017-2022)
  • Table 9. MicroRNA Consumables Neurological Disease , by Region USD Million (2017-2022)
  • Table 10. MicroRNA Consumables Others , by Region USD Million (2017-2022)
  • Table 11. MicroRNA Consumables: by End Use(USD Million)
  • Table 12. MicroRNA Consumables Biotechnology , by Region USD Million (2017-2022)
  • Table 13. MicroRNA Consumables Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 14. MicroRNA Consumables Academic , by Region USD Million (2017-2022)
  • Table 15. MicroRNA Consumables Government Research Institutes , by Region USD Million (2017-2022)
  • Table 16. MicroRNA Consumables Others , by Region USD Million (2017-2022)
  • Table 17. MicroRNA Consumables: by Service(USD Million)
  • Table 18. MicroRNA Consumables Isolation & Purification , by Region USD Million (2017-2022)
  • Table 19. MicroRNA Consumables Quantification & Detection , by Region USD Million (2017-2022)
  • Table 20. MicroRNA Consumables Functional Analysis , by Region USD Million (2017-2022)
  • Table 21. MicroRNA Consumables Others , by Region USD Million (2017-2022)
  • Table 22. South America MicroRNA Consumables, by Country USD Million (2017-2022)
  • Table 23. South America MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 24. South America MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 25. South America MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 26. South America MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 27. Brazil MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 28. Brazil MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 29. Brazil MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 30. Brazil MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 31. Argentina MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 32. Argentina MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 33. Argentina MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 34. Argentina MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 35. Rest of South America MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 36. Rest of South America MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 37. Rest of South America MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 38. Rest of South America MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 39. Asia Pacific MicroRNA Consumables, by Country USD Million (2017-2022)
  • Table 40. Asia Pacific MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 41. Asia Pacific MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 42. Asia Pacific MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 43. Asia Pacific MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 44. China MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 45. China MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 46. China MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 47. China MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 48. Japan MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 49. Japan MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 50. Japan MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 51. Japan MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 52. India MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 53. India MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 54. India MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 55. India MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 56. South Korea MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 57. South Korea MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 58. South Korea MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 59. South Korea MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 60. Taiwan MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 61. Taiwan MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 62. Taiwan MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 63. Taiwan MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 64. Australia MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 65. Australia MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 66. Australia MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 67. Australia MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 72. Europe MicroRNA Consumables, by Country USD Million (2017-2022)
  • Table 73. Europe MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 74. Europe MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 75. Europe MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 76. Europe MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 77. Germany MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 78. Germany MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 79. Germany MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 80. Germany MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 81. France MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 82. France MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 83. France MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 84. France MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 85. Italy MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 86. Italy MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 87. Italy MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 88. Italy MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 89. United Kingdom MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 90. United Kingdom MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 91. United Kingdom MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 92. United Kingdom MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 93. Netherlands MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 94. Netherlands MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 95. Netherlands MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 96. Netherlands MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 97. Rest of Europe MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 98. Rest of Europe MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 99. Rest of Europe MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 100. Rest of Europe MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 101. MEA MicroRNA Consumables, by Country USD Million (2017-2022)
  • Table 102. MEA MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 103. MEA MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 104. MEA MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 105. MEA MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 106. Middle East MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 107. Middle East MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 108. Middle East MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 109. Middle East MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 110. Africa MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 111. Africa MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 112. Africa MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 113. Africa MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 114. North America MicroRNA Consumables, by Country USD Million (2017-2022)
  • Table 115. North America MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 116. North America MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 117. North America MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 118. North America MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 119. United States MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 120. United States MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 121. United States MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 122. United States MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 123. Canada MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 124. Canada MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 125. Canada MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 126. Canada MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 127. Mexico MicroRNA Consumables, by Type USD Million (2017-2022)
  • Table 128. Mexico MicroRNA Consumables, by Application USD Million (2017-2022)
  • Table 129. Mexico MicroRNA Consumables, by End Use USD Million (2017-2022)
  • Table 130. Mexico MicroRNA Consumables, by Service USD Million (2017-2022)
  • Table 131. MicroRNA Consumables: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. MicroRNA Consumables: by Type(USD Million)
  • Table 143. MicroRNA Consumables Instruments , by Region USD Million (2023-2028)
  • Table 144. MicroRNA Consumables Consumables , by Region USD Million (2023-2028)
  • Table 145. MicroRNA Consumables: by Application(USD Million)
  • Table 146. MicroRNA Consumables Cancer , by Region USD Million (2023-2028)
  • Table 147. MicroRNA Consumables Infectious Diseases , by Region USD Million (2023-2028)
  • Table 148. MicroRNA Consumables Immunological Disorder , by Region USD Million (2023-2028)
  • Table 149. MicroRNA Consumables Cardiovascular Disease , by Region USD Million (2023-2028)
  • Table 150. MicroRNA Consumables Neurological Disease , by Region USD Million (2023-2028)
  • Table 151. MicroRNA Consumables Others , by Region USD Million (2023-2028)
  • Table 152. MicroRNA Consumables: by End Use(USD Million)
  • Table 153. MicroRNA Consumables Biotechnology , by Region USD Million (2023-2028)
  • Table 154. MicroRNA Consumables Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 155. MicroRNA Consumables Academic , by Region USD Million (2023-2028)
  • Table 156. MicroRNA Consumables Government Research Institutes , by Region USD Million (2023-2028)
  • Table 157. MicroRNA Consumables Others , by Region USD Million (2023-2028)
  • Table 158. MicroRNA Consumables: by Service(USD Million)
  • Table 159. MicroRNA Consumables Isolation & Purification , by Region USD Million (2023-2028)
  • Table 160. MicroRNA Consumables Quantification & Detection , by Region USD Million (2023-2028)
  • Table 161. MicroRNA Consumables Functional Analysis , by Region USD Million (2023-2028)
  • Table 162. MicroRNA Consumables Others , by Region USD Million (2023-2028)
  • Table 163. South America MicroRNA Consumables, by Country USD Million (2023-2028)
  • Table 164. South America MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 165. South America MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 166. South America MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 167. South America MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 168. Brazil MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 169. Brazil MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 170. Brazil MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 171. Brazil MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 172. Argentina MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 173. Argentina MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 174. Argentina MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 175. Argentina MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 176. Rest of South America MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 177. Rest of South America MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 178. Rest of South America MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 179. Rest of South America MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 180. Asia Pacific MicroRNA Consumables, by Country USD Million (2023-2028)
  • Table 181. Asia Pacific MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 182. Asia Pacific MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 183. Asia Pacific MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 184. Asia Pacific MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 185. China MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 186. China MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 187. China MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 188. China MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 189. Japan MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 190. Japan MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 191. Japan MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 192. Japan MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 193. India MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 194. India MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 195. India MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 196. India MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 197. South Korea MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 198. South Korea MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 199. South Korea MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 200. South Korea MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 201. Taiwan MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 202. Taiwan MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 203. Taiwan MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 204. Taiwan MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 205. Australia MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 206. Australia MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 207. Australia MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 208. Australia MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 209. Rest of Asia-Pacific MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 210. Rest of Asia-Pacific MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 211. Rest of Asia-Pacific MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 212. Rest of Asia-Pacific MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 213. Europe MicroRNA Consumables, by Country USD Million (2023-2028)
  • Table 214. Europe MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 215. Europe MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 216. Europe MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 217. Europe MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 218. Germany MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 219. Germany MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 220. Germany MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 221. Germany MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 222. France MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 223. France MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 224. France MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 225. France MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 226. Italy MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 227. Italy MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 228. Italy MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 229. Italy MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 230. United Kingdom MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 231. United Kingdom MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 232. United Kingdom MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 233. United Kingdom MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 234. Netherlands MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 235. Netherlands MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 236. Netherlands MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 237. Netherlands MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 238. Rest of Europe MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 239. Rest of Europe MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 240. Rest of Europe MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 241. Rest of Europe MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 242. MEA MicroRNA Consumables, by Country USD Million (2023-2028)
  • Table 243. MEA MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 244. MEA MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 245. MEA MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 246. MEA MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 247. Middle East MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 248. Middle East MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 249. Middle East MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 250. Middle East MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 251. Africa MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 252. Africa MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 253. Africa MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 254. Africa MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 255. North America MicroRNA Consumables, by Country USD Million (2023-2028)
  • Table 256. North America MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 257. North America MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 258. North America MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 259. North America MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 260. United States MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 261. United States MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 262. United States MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 263. United States MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 264. Canada MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 265. Canada MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 266. Canada MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 267. Canada MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 268. Mexico MicroRNA Consumables, by Type USD Million (2023-2028)
  • Table 269. Mexico MicroRNA Consumables, by Application USD Million (2023-2028)
  • Table 270. Mexico MicroRNA Consumables, by End Use USD Million (2023-2028)
  • Table 271. Mexico MicroRNA Consumables, by Service USD Million (2023-2028)
  • Table 272. MicroRNA Consumables: by Type(USD/Units)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global MicroRNA Consumables: by Type USD Million (2017-2022)
  • Figure 5. Global MicroRNA Consumables: by Application USD Million (2017-2022)
  • Figure 6. Global MicroRNA Consumables: by End Use USD Million (2017-2022)
  • Figure 7. Global MicroRNA Consumables: by Service USD Million (2017-2022)
  • Figure 8. South America MicroRNA Consumables Share (%), by Country
  • Figure 9. Asia Pacific MicroRNA Consumables Share (%), by Country
  • Figure 10. Europe MicroRNA Consumables Share (%), by Country
  • Figure 11. MEA MicroRNA Consumables Share (%), by Country
  • Figure 12. North America MicroRNA Consumables Share (%), by Country
  • Figure 13. Global MicroRNA Consumables: by Type USD/Units (2017-2022)
  • Figure 14. Global MicroRNA Consumables share by Players 2022 (%)
  • Figure 15. Global MicroRNA Consumables share by Players (Top 3) 2022(%)
  • Figure 16. Global MicroRNA Consumables share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 20. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 21. Agilent Technologies (United States) Revenue: by Geography 2022
  • Figure 22. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 24. Exiqon A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 25. Exiqon A/S (Denmark) Revenue: by Geography 2022
  • Figure 26. NanoString Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 27. NanoString Technologies (United States) Revenue: by Geography 2022
  • Figure 28. GE Healthcare Dharmacon, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. GE Healthcare Dharmacon, Inc. (United States) Revenue: by Geography 2022
  • Figure 30. Synlogic (United States) Revenue, Net Income and Gross profit
  • Figure 31. Synlogic (United States) Revenue: by Geography 2022
  • Figure 32. GeneCopoeia, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. GeneCopoeia, Inc. (United States) Revenue: by Geography 2022
  • Figure 34. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 35. New England Biolabs (United States) Revenue: by Geography 2022
  • Figure 36. Quantabio (United States) Revenue, Net Income and Gross profit
  • Figure 37. Quantabio (United States) Revenue: by Geography 2022
  • Figure 38. Global MicroRNA Consumables: by Type USD Million (2023-2028)
  • Figure 39. Global MicroRNA Consumables: by Application USD Million (2023-2028)
  • Figure 40. Global MicroRNA Consumables: by End Use USD Million (2023-2028)
  • Figure 41. Global MicroRNA Consumables: by Service USD Million (2023-2028)
  • Figure 42. South America MicroRNA Consumables Share (%), by Country
  • Figure 43. Asia Pacific MicroRNA Consumables Share (%), by Country
  • Figure 44. Europe MicroRNA Consumables Share (%), by Country
  • Figure 45. MEA MicroRNA Consumables Share (%), by Country
  • Figure 46. North America MicroRNA Consumables Share (%), by Country
  • Figure 47. Global MicroRNA Consumables: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
  • Agilent Technologies (United States)
  • Merck KGaA (Germany)
  • Exiqon A/S (Denmark)
  • NanoString Technologies (United States)
  • GE Healthcare Dharmacon, Inc. (United States)
  • Synlogic (United States)
  • GeneCopoeia, Inc. (United States)
  • New England Biolabs (United States)
  • Quantabio (United States)
Additional players considered in the study are as follows:
BioGenex (United States) , SeqMatic LLC (United States) , Miltenyi Biotec (Germany) , Others
Select User Access Type

Key Highlights of Report


Dec 2023 229 Pages 91 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global MicroRNA Consumables Market Quantitative research analysis
Global MicroRNA Consumables Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global MicroRNA Consumables market are Thermo Fisher Scientific (United States), Agilent Technologies (United States), Merck KGaA (Germany), Exiqon A/S (Denmark), NanoString Technologies (United States), GE Healthcare Dharmacon, Inc. (United States), Synlogic (United States), GeneCopoeia, Inc. (United States), New England Biolabs (United States) and Quantabio (United States), to name a few.
"Advance Methodologies Used for MicroRNA Consumables, RNA Sequencing, and Microarray " is seen as one of major influencing trends for MicroRNA Consumables Market during projected period 2022-2028.
Instruments segment in Global market to hold robust market share owing to "High Prevalence and Rise of Cancer Neurological Disorder and Other Medical Conditions ".

Know More About Global MicroRNA Consumables Market Report?

Have a Query? Click Here

Other Related Reports

Fenofibric Acid Comprehensive Study by Type (45 mg Delayed Release Capsules, 135 mg Delayed Release Capsules), Application (Hospital, Drug store) Players and Region - Global Market Outlook to 2030
$ 3500
Molecular Diagnostics Comprehensive Study by Type (Instruments, Reagents, Software & Services), Application (Infectious Diseases (HIV, HPV, Tuberculosis and Other Infectious Diseases), Oncology (Brea...
$ 3750
Thyroid Function Tests Comprehensive Study by Type (TSH Tests (Thyroid Stimulating Hormone Test), FT4 Tests (Free T4), FT3 Tests (Free T3)), End User (Hospitals, Diagnostic Laboratories, Research Lab...
$ 3350
Cancer Profiling Comprehensive Study by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Others (Melanoma, Colorectal, Bladder, Leukemia)), Application (Clinical, Scr...
$ 3750
Multipurpose Systems Comprehensive Study by Application (Ambulance, RHC, Home care, Intensive care room), Components (Hardware, Software), Modules (Biosignal acquisition module, Digital camera, Proce...
$ 3450
Fertility Services Comprehensive Study by Application (Fertility clinics, Hospitals, Surgical centers, Clinical Research Institutes), Treatment (Assistive reproductive technology (ART) (Artificial in...
$ 3750